Teri Pollastro was diagnosed with HER2+ metastatic breast cancer in 2003 when her children were 3 and 7. Teri was treated with chemotherapy, a monoclonal antibody, shaped beam radiation treatment (SBRT), and participated in a phase 1 vaccine clinical trial. She remains on Herceptin today.
Teri has been involved in a variety of advocacy projects both locally and nationally. She currently serves as the co-chair for the NWMetastatic Breast Cancer Conference and the Metastatic Breast Cancer Alliance Research Task Force Committee. Teri is the research advocate representing the University of WA for the Translational Breast Cancer Research Consortium and serves on numerous grants as an advocate/advocate mentor. Teri is an Advocate in Science (AIS) for Susan G. Komen and serves on their metastatic breast cancer patient committee.
In her spare time, Teri enjoys spending time with her family, reading, traveling, hiking, and playing tennis (not very well).
WHAT I'M WORKING ON
Thought Leader Interviews and Survey
The MBCA has begun work to update this section of Chapter 2 of the Landscape Analysis, report the current landscape of MBC research, and gather knowledge that will inform the 5-year MBCA strategic plan beginning in 2022.Link to program
MBC Research Funding Update
As in the original analysis, the research grant analysis in 2021 and subsequent years will help to identify gaps in research and opportunities for future Alliance resource allocation and provide insight into new drug targets or potential targets poised for development and clinical translation that may further inform Alliance priorities or activities.Link to program